Pricing Log in Create free account

AN2 Therapeutics, Inc. (ANTX) vs Tiziana Life Sciences Ltd (TLSA)

AN2 Therapeutics, Inc. and Tiziana Life Sciences Ltd are both Biotechnology companies. AN2 Therapeutics, Inc. and Tiziana Life Sciences Ltd are of similar size ($135.9M and $134.7M). Across the 7 metrics below, Tiziana Life Sciences Ltd leads on 4 and AN2 Therapeutics, Inc. on 3.

Valuation

Metric ANTX TLSA Biotechnology median
P/E n/m n/m 8.42
P/S n/m n/m 10.01
P/B 2.12 n/m 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m 0.04 0.61
EV/Sales n/m n/m 9.41
Earnings yield (29.81%) (50.37%) (31.85%)
Free cash flow yield (19.09%) 0.00% (24.58%)

Profitability

Metric ANTX TLSA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.12%) 0.00% (56.36%)
Return on assets (46.06%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANTX TLSA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 32.56% (45.45%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANTX TLSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.32 0.76 4.72
Net debt to EBITDA 1.48 0.19 0.96

Dividend

Metric ANTX TLSA Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ANTX TLSA Biotechnology median
Market cap 135.85m 134.73m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack